Dive deep into the Patented Medicines Prices Review Board’s new guidelines with Guillaume Couillard, of PMPRB. Learn about key changes in price monitoring, stakeholder engagement, and how these updates will impact pharmaceutical companies in Canada. Discover the PMPRB’s evolving mandate, scientific review process, and what to expect in 2025. Essential viewing for pharma executives, policy makers, and industry professionals.
Key Highlights:
– New international price comparison approach
– Changes in price monitoring methodology
– Stakeholder consultation insights
– Future of pharmaceutical pricing in Canada
#PMPRB #PharmaceuticalRegulation #CanadianHealthPolicy
Guillaume Couillard
PMPRB
05 Jun 2025
47min 43sec
Dive deep into the complex world of Preferred Pharmacy Networks (PPNs) with industry experts Stephanie Babbitt of Sanofi, Sandra Hanna of NPAC, and Bruce Winston of Neighbourhood Pharmacy. Hear about key challenges and opportunities from pharmacy, pharmaceutical manufacturing, and patient …...
22 May 2025
48min 05sec
A panel of healthcare experts, Declan Hamill, Christian Ouelett, Laura Syron and Joan Weir, discuss the complexities of Canada’s new PharmaCare legislation, exploring its potential impact on patients, pharmaceutical industries, and healthcare systems. Key topics include drug access, cost implications, …...
